David Y. Norton

Director, Savient Pharmaceuticals.

Companies

Compass PathwaysBoard member Jan 3, 2022 to now¹
Keenova Therapeutics plcBoard member Sep 22, 2017 to Jun 21, 2022²
VivusBoard member Jul 29, 2013 to Feb 24, 2020³
Syneos Health, Inc.Board member Feb 4, 2015 to May 24, 2017⁴
Savient PharmaceuticalsBoard member Sep 6, 2011 to Jul 20, 2012⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Compass Pathways CMPS20,356 shares⁶$223.9K at $11.00Mar 29, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Mar 29, 2022Sold 3,384 shares at $12.48 of Compass Pathways⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARCompass Pathways, Board member
2
SEC EDGARKeenova Therapeutics plc, Board member
3
SEC EDGARVivus, Board member
4
SEC EDGARSyneos Health, Inc., Board member
5
SEC EDGARSavient Pharmaceuticals, Board member
6
SEC EDGARCompass Pathways shares after the filing of Mar 29, 2022